Literature DB >> 8806082

Ligand-specificity of the selectins.

D Vestweber1.   

Abstract

The selectins are carbohydrate-binding cell adhesion molecules acting in the vascular system. They mediate the docking of leukocytes to the blood vessel wall and the rolling of these cells along the endothelial cell surface. These adhesion phenomena initiate the entry of leukocytes into sites of inflammation as well as the migration of recirculating lymphocytes into secondary lymphoid tissues. Blocking selectin function with antibodies or oligosaccharides has proven to be beneficial in various animal models of inflammation and models of ischemia/reperfusion damage. This has raised much interest in the identification of the physiological ligands of the selectins. Several glycoprotein ligands have been identified, some of which can even be selectively isolated from cellular detergent extracts using a selectin as an affinity probe. Four of these "high affinity" ligands have been cloned. The structural requirements of their interaction with the selectins is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806082     DOI: 10.1002/(SICI)1097-4644(19960616)61:4%3C585::AID-JCB12%3E3.0.CO;2-F

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

Authors:  Y J Kim; L Borsig; H L Han; N M Varki; A Varki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  Beta1-integrin-mediated dynamic adhesion of colon carcinoma cells to extracellular matrix under laminar flow.

Authors:  J Haier; M Y Nasralla; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

Review 3.  Selectin ligands: will the real ones please stand up?

Authors:  A Varki
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

4.  Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.

Authors:  A Koenig; K Norgard-Sumnicht; R Linhardt; A Varki
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 5.  In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands.

Authors:  R Renkonen; P Mattila; M L Majuri; J Räbinä; S Toppila; J Renkonen; L Hirvas; J Niittymäki; J P Turunen; O Renkonen; T Paavonen
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

6.  Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration.

Authors:  J Yang; T Hirata; K Croce; G Merrill-Skoloff; B Tchernychev; E Williams; R Flaumenhaft; B C Furie; B Furie
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

7.  Structural characterisation of neutrophil glycans by ultra sensitive mass spectrometric glycomics methodology.

Authors:  Ponnusamy Babu; Simon J North; Jihye Jang-Lee; Sara Chalabi; Kathryn Mackerness; Sean R Stowell; Richard D Cummings; Sara Rankin; Anne Dell; Stuart M Haslam
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.